Is Exemestane Tablets really a targeted drug?
Exemestane tablets are generally not targeted drugs; they belong to a class of anti-tumor medications. Please follow medical advice when taking this medication.

Targeted drugs usually refer to those capable of precisely identifying and attacking specific molecular markers on the surface of tumor cells, such as antibody-drug conjugates and tyrosine kinase inhibitors. Exemestane tablets generally are not considered targeted drugs. This medication belongs to anti-tumor drugs and does not possess the characteristics of targeted drugs. It is primarily used for endocrine therapy in postmenopausal estrogen receptor-positive breast cancer patients.
Exemestane tablets work by competitively binding to estrogen receptors on cell surfaces, blocking the stimulatory effect of endogenous estrogen on tumor cell growth, thereby inhibiting the proliferation of breast cancer cells. For hormone receptor-positive breast cancer patients, Exemestane tablets can specifically block tumor growth and reduce side effects.
It is recommended to seek timely medical attention and undergo treatment according to individual circumstances. During treatment, patients should also follow medical instructions and have regular follow-up examinations to allow timely adjustment of treatment plans.